Phenotypes Associated with This Genotype

Genotype
MGI:5556113

• Allelic Composition: Tg(H2-L-IL6)40Csk/0
• Genetic Background: involves: C57BL/6

• ♀: phenotype observed in females
• ♂: phenotype observed in males
• N: normal phenotype

immune system

enlarged spleen ( J:207264 )

• prior to and after tocilizumab treatment

• however, treatment with MR16-1 prevents development of splenomegaly

increased spleen weight ( J:207264 )

• however, treatment with MR16-1 prevents development of splenomegaly

enlarged lymph nodes ( J:207264 )

hematopoietic system

enlarged spleen ( J:207264 )

• prior to and after tocilizumab treatment

• however, treatment with MR16-1 prevents development of splenomegaly

increased spleen weight ( J:207264 )

• however, treatment with MR16-1 prevents development of splenomegaly

growth/size/body

enlarged spleen ( J:207264 )

• prior to and after tocilizumab treatment

• however, treatment with MR16-1 prevents development of splenomegaly

increased spleen weight ( J:207264 )

• however, treatment with MR16-1 prevents development of splenomegaly